Top Markets
Coin of the day
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
Classifica tra le azioni #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
Prezzo delle azioni
$0.94
Ultima sincronizzazione: 2025-02-28
Capitalizzazione di mercato
$2.73M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Fresh Tracks Therapeutics, Inc. (FRTX)

Categoria

Storico del prezzo dell'azione per Fresh Tracks Therapeutics, Inc. (FRTX)
Prezzo di chiusura più alto: $0.93 il 2025-02-01

Prezzo di chiusura più basso: $17.60K il 1993-03-01
Storico del prezzo dell'azione di Fresh Tracks Therapeutics, Inc. dal 1993 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 25.41%
2024 -12.67%
2023 -44.20%
2022 -87.64%
2021 -62.29%
2020 -56.41%
2019 -79.67%
2018 -35.82%
2017 -21.99%
2016 -41.65%
2015 -62.32%
2014 -5.40%
2013 -62.56%
2012 -33.38%
2011 129.70%
2010 -33.25%
2009 132.91%
2008 -71.15%
2007 -34.72%
2006 40.95%
2005 4.97%
2004 -6.60%
2003 35.73%
2002 -70.26%
2001 -36.17%
2000 -14.37%
1999 47.84%
1998 16.60%
1997 -25.73%
1996 63.98%
1995 35.35%
1994 -42.99%
1993 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE